How cool would it be to program DNA at home to make gifs or play Tetris? Well, this device will soon let you do just that. Cell-Free Technologies wants to…
…DNA. In the case of tumor cells that are already impaired with mutations in their DNA repair machinery, this strategy can quickly kill the tumor. However, current DDR drugs can…
…a number of biotechs in this area, including DNAlytics’ test for arthritic diseases and Ampligen’s HPV test for uterine cancer. DNA testing technology is now becoming more and more accessible…
…development of recombinant DNA technology to the current state of the field. With DNA sequencing and synthesis costs lower than ever, Berry thinks our ability to control genes precisely will…
…DNA in real time with high accuracy. As DNA passes through the nanopore, it causes changes in current which can be detected and used to sequence the DNA. Oxford Nanopore…
…of big Pharma? Nuevolution’s high-throughput drug discovery platform, Chemetics, uses DNA barcodes to identify every molecule. The candidates that bind best to the desired target can then be quickly identified…
A team of Canadian researchers from Université de Montréal has designed and validated a new class of drug transporters made of DNA 20,000 times smaller than a human hair. The…
Replay, a genome writing company reprogramming biology by writing and delivering big DNA, has launched with $55 million in seed financing. The round was led by KKR and OMX Ventures,…
Today, we’re in Oxford, UK, visiting Orbit Discovery. The biotech develops peptide drugs for chronic diseases using DNA to tag potential therapeutic proteins. Mission: Orbit Discovery develops peptide drugs for…
Sterna Biologicals has obtained positive Phase IIa data for an ulcerative colitis treatment that uses DNA to inhibit inflammatory proteins, which could add to the diverse approaches being developed to…
Belgian biotech OncoDNA has raised €19M in Series B funding to further develop its cancer diagnostic and therapeutic decision-making software. The funding was led by Vesalius Biocapital, a Luxembourg-based VC…
…developed its Gene Transfer Unit (GTU) that safely and efficiently transfers DNA to target cells. The technology can be used to make DNA-based vaccines and in gene therapies. Though FIT…